Introducti on:Following the fi rst study of Computed tomography guided trans thoracic biopsy of lung lesion by Haaga and Alfi di in 1976, CT guided transthoracic biopsy has been widely used for confi rming the diagnosis of suspicious lung lesions. This study is aimed to assess the eff ecti veness of Transthoracic percutaneous fi ne needle aspirati on cytology and frequency of associated complicati ons.
INTRODUCTION
Both neoplasti c (benign and malignant) and nonneoplasti c lung parenchymal lesions are common pathological lung fi ndings. There are many diagnosti c tools and tests available including the simple sputum examinati on to broncheo-alveloar lavage and endoscopic bronchial biopsies. Ultrasound guided, fl uroscopy guided, MRI guided and open lung biopsies remain the other invasive opti ons available.
The fi rst aspirati on biopsy (puncture of lung) was performed by Leyden, for the diagnosis of pneumonia in 1883 1 . Dahlgren and Nordenstorm 2 published a study concluding 87% diagnosti c accuracy in 1966 following which, trans-thoracic FNAC gained wider acceptance. Haaga and Alfi di reported the fi rst Computed Tomography (CT)-guided lung biopsy in 1976 3 .
CT-guided percutaneous fi ne-needle aspirati on cytology (FNAC) of suspicious lung lesions is a widely accepted diagnosti c method with relati vely low cost and negligible mortality and limited morbidity. FNAC is helpful in confi rming the diagnosis (benign or malignant nature) which would help the clinicians in deciding the therapeuti c management 4 .
Objecti ve of this study was to determine the accuracy and complicati ons of CT-guided FNAC at our center and evaluate the pathological spectrum of the lung nodules/masses. Chest pain at FNAC site, haemorrhage, haemoptysis and pneumothorax are some of the common complicati ons associated with trans-thoracic FNAC of the lung nodule. The more serious complicati ons include pericaridaltamponade, systemic air embolism and seeding of malignant cells in the needle tract.
METHODS
Case records of thirty nine pati ents with lung lesions on plain CXR and CECT chest who underwent CT guided FNAC of thoracic lesions between 11/06/2008 and 1/12/2009 was reviewed aft er seeking insti tuti onal consent. Pre procedure investi gati ons and informed consent was obtained as per the insti tuti on protocol.
All pati ents underwent prior CECT of the chest to characterize the lung lesion. Pati ents with severe COPD who could not hold breath for a long ti me, pati ents having bleeding disorders and pati ents with contralateral pneumonectomy were excluded from the study. A fi ne spinal needle (23 gauge chibaneedle ) was used for the FNAC. If the specimen sample obtained during the FNAC was inadequate for cytology, the procedure was repeated. If that provided a negati ve yield, the pati ent was referred for more invasive procedures such as tru cut biopsy and open biopsy thoracotomy.
Diagnosti c accuracy was measured on basis of adequacy of sample for defi nite cytopathological diagnosis. Safety was measured in terms of complicati on rates. Feasibility in terms of the durati on of post procedure hospital stay and total att empts required. We assumed age, sex and presence of emphysema as pati ent related variables. Size, depth of the lesion and locati on as the tumour related variables.
The procedure was conducted in the Radiology department at Shree Birendra Hospital. CT scan was performed to localize the lesion and skin entry point was marked with skin marker. Lidocaine (2%) was used as local anesthesia and the same needle was left in place for reference as a single axial scan was obtained for tumour localizati on. A spinal needle (23 gauge Chiba needle) was used for the procedure. Needle ti p positi on was confi rmed with additi onal limited CT scans before the sample for cytology was obtained. A syringe (10 ml) was att ached to the needle's hub and the plunger pulled back to provide conti nuous sucti on. The needle point within the lesion was jiggled to free material from the lesion into the needle's lumen. Aspirates were obtained and smeared on slides, fi xed in 95 % alcohol before being sent to the pathology department for cytological evaluati on along with relevant history and radiological fi ndings.
A limited CT scan was performed immediately at the site of the FNAC to exclude pneumothorax and other FNAC related complicati ons. The pati ents who developed pneumothorax, were kept under strict observati on to monitor further deteriorati on. A repeat chest radiograph was performed next morning to assess progression of disease.
RESULTS
Thirty-nine cases were included in the study. Out of these, twenty four pati ents (61.54%), were male and fi ft een (38.46 %) were female in the age group 25-82 years. Out of thirty-nine pati ents, twenty eight were smokers or had smoked in the past (71.79%).
Diagnosti c accuracy was calculated based on the fi nal cytopathological report. There was adequate material in thirty four (87.18 %) cases while fi ve cases (12.82%) represented inadequate and non representati ve material (Two cases were hemorrhagic while three cases revealed only reacti ve cells).
Out of the thirty four pati ents where a fi nal diagnosis was available, eight cases were reported as benign (23.53 %), twenty three samples were reported as defi nite malignant cases (67.65 %) and three cases showed atypical cells (8.82%), suggesti ve of malignancy. The spectrum of the fi nal diagnosis of all the pati ents is given below in table 1.
Of the twenty three cases of confi rmed malignacies, twelve were squamous cell carcinoma, three were small cell anaplasti c carcinoma, three were metastati c lesions , two were adenocarcinoma, one was bronchioalveolar carcinoma , one was lymphoma and one was thymoma.
Out of the eight benign cases, four cases were reported as tuberculosis, two cases as benign adenoma and two cases as non tubercular infecti on. Six (17.65 %) of the pati ents were under 40 yrs and none had malignancy in cytodiagnosis.
Pneumothorax was the commonest complicati on following the TTFNAC. Minimal pneumothorax was noted in four cases (10.26%) but none required acti ve management (placement of chest tube). Pain at the puncture site was observed with two pati ents (5.13 %) requiring oral NSAID and reassurance. Two pati ents (5.13%) experienced minimal hemoptysis immediately following the procedure (both pati ents had also developed pneumothorax). A total of six pati ents who underwent CT guided FNAC developed complicati ons (15.38%) We conclude that Transthoracic fi ne needle aspirati on cytology (FNAC) of lung lesion using CT guidance is a relati vely safe and accurate means of diagnosing benign and malignant lesions of the chest with negligible mortality and limited mortality. All the pati ents tolerated the procedure well. The most common complicati on following procedure was pneumothorax. Pneumothorax occurred in 4 (10.26%) cases and haemoptysis in two cases (5.13 %) case. In all 4 cases, the pneumothorax was noted within 10 minutes of the procedure and it was mild in amount. 2 pati ent complaint of pain at site of puncture lasti ng 4-8 hours, however no medicati on was needed. These pati ents were kept under strict observati on for any deteriorati on. A chest radiograph was done aft er 4 hours and it was observed that the amount of pneumothorax was mild to moderate (<1/3rd of chest) in all the case. None of these pati ents required chest tube inserti on. No evidence of intra-parenchymal haematoma was noted. The more serious complicati ons such as pericardial tamponade, systemic air embolism and seeding of malignant cells in the needle tract were not encountered in our study.
The results of the diagnosti c accuracy and complicati on of CT-guide aspirati on cytology are comparable to other published studies Table 2 .
CONCLUSIONS
Transthoracic Fine Needle Aspirati on Cytology is a relati vely safe, convenient, quick and economical procedure. We conclude that FNAC of lung lesion provides a high yield resulti ng in good diagnosti c accuracy.
